Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102867783 | 10286778 | 3 | F | 20070124 | 20160819 | 20140709 | 20160902 | EXP | US-ACTELION-A-US2014-101185 | ACTELION | 90.00 | YR | E | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102867783 | 10286778 | 1 | PS | TRACLEER | BOSENTAN | 1 | Oral | 125 MG, BID | Y | 21290 | 125 | MG | TABLET | BID | |||||
| 102867783 | 10286778 | 2 | C | SILDENAFIL. | SILDENAFIL | 1 | U | 0 | |||||||||||
| 102867783 | 10286778 | 3 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QAM | U | 0 | 20 | MG | QD | ||||||
| 102867783 | 10286778 | 4 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, QPM | U | 0 | 20 | MG | QD | ||||||
| 102867783 | 10286778 | 5 | C | REMERON | MIRTAZAPINE | 1 | 15 MG, QPM | U | 0 | 15 | MG | QD | |||||||
| 102867783 | 10286778 | 6 | C | CEPHULAC | LACTULOSE | 1 | Oral | 15 ML, BID | U | 0 | 15 | ML | BID | ||||||
| 102867783 | 10286778 | 7 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0.5 T, BID | U | 0 | BID | |||||||||
| 102867783 | 10286778 | 8 | C | PROCTOFOAM | PRAMOXINE HYDROCHLORIDE | 1 | Rectal | UNK, BID | U | 0 | BID | ||||||||
| 102867783 | 10286778 | 9 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | 0.5 MG, QID | U | 0 | .5 | MG | QID | |||||||
| 102867783 | 10286778 | 10 | C | TEARS RENEWED | 2 | UNK, QID | U | 0 | QID | ||||||||||
| 102867783 | 10286778 | 11 | C | DOCUSATE | DOCUSATE | 1 | Oral | 200 MG, QPM | U | 0 | 200 | MG | QD | ||||||
| 102867783 | 10286778 | 12 | C | PREPARATION H NOS | COCOA BUTTERPETROLATUMPHENYLEPHRINE HYDROCHLORIDEPHENYLEPHRINE HYDROCHLORIDE OR MINERAL OIL | 1 | Rectal | UNK, BID | U | 0 | BID | ||||||||
| 102867783 | 10286778 | 13 | C | ACCUNEB | ALBUTEROL SULFATE | 1 | 0.63 MG, QID | U | 0 | .63 | MG | QID | |||||||
| 102867783 | 10286778 | 14 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 2 PUFF, Q4HRS | U | 0 | Q4H | |||||||||
| 102867783 | 10286778 | 15 | C | ANUSOL HC | HYDROCORTISONE | 1 | Rectal | 25 MG, BID | U | 0 | 25 | MG | BID | ||||||
| 102867783 | 10286778 | 16 | C | ARANESP | DARBEPOETIN ALFA | 1 | 100 MCG, UNK | U | 0 | 100 | UG | ||||||||
| 102867783 | 10286778 | 17 | C | BUMEX | BUMETANIDE | 1 | 1 MG, UNK | U | 0 | 1 | MG | ||||||||
| 102867783 | 10286778 | 18 | C | DILTIAZEM XR | DILTIAZEM | 1 | 120 MG, UNK | U | 0 | 120 | MG | ||||||||
| 102867783 | 10286778 | 19 | C | COREG | CARVEDILOL | 1 | 3.125 MG, UNK | U | 0 | 3.125 | MG | ||||||||
| 102867783 | 10286778 | 20 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 102867783 | 10286778 | 21 | C | DIOVAN | VALSARTAN | 1 | 160 MG, UNK | U | 0 | 160 | MG | ||||||||
| 102867783 | 10286778 | 22 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, UNK | U | 0 | 81 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102867783 | 10286778 | 1 | Pulmonary arterial hypertension |
| 102867783 | 10286778 | 6 | Constipation |
| 102867783 | 10286778 | 7 | Pain |
| 102867783 | 10286778 | 14 | Wheezing |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102867783 | 10286778 | HO |
| 102867783 | 10286778 | LT |
| 102867783 | 10286778 | OT |
| 102867783 | 10286778 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102867783 | 10286778 | Abdominal distension | |
| 102867783 | 10286778 | Acute kidney injury | |
| 102867783 | 10286778 | Adjustment disorder | |
| 102867783 | 10286778 | Alcoholism | |
| 102867783 | 10286778 | Anxiety | |
| 102867783 | 10286778 | Ascites | |
| 102867783 | 10286778 | Atrial fibrillation | |
| 102867783 | 10286778 | Blepharitis | |
| 102867783 | 10286778 | Cardiac failure | |
| 102867783 | 10286778 | Chronic kidney disease | |
| 102867783 | 10286778 | Cor pulmonale | |
| 102867783 | 10286778 | Cystoid macular oedema | |
| 102867783 | 10286778 | Dry eye | |
| 102867783 | 10286778 | Dyspnoea | |
| 102867783 | 10286778 | Dyspnoea exertional | |
| 102867783 | 10286778 | Generalised oedema | |
| 102867783 | 10286778 | Glaucoma | |
| 102867783 | 10286778 | Hepatic cirrhosis | |
| 102867783 | 10286778 | Hepatic neoplasm | |
| 102867783 | 10286778 | Hypotension | |
| 102867783 | 10286778 | Intraocular lens implant | |
| 102867783 | 10286778 | Iron deficiency anaemia | |
| 102867783 | 10286778 | Mixed incontinence | |
| 102867783 | 10286778 | Nephrogenic anaemia | |
| 102867783 | 10286778 | Osteoarthritis | |
| 102867783 | 10286778 | Pericardial effusion | |
| 102867783 | 10286778 | Peritonitis bacterial | |
| 102867783 | 10286778 | Persistent depressive disorder | |
| 102867783 | 10286778 | Pulmonary fibrosis | |
| 102867783 | 10286778 | Respiratory failure | |
| 102867783 | 10286778 | Right ventricular failure | |
| 102867783 | 10286778 | Rotator cuff syndrome | |
| 102867783 | 10286778 | Urge incontinence | |
| 102867783 | 10286778 | Urinary tract infection | |
| 102867783 | 10286778 | Vitreous detachment | |
| 102867783 | 10286778 | Vitritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102867783 | 10286778 | 1 | 2006 | 20140507 | 0 |